Biotricity is a medical technology company focused on biometric data monitoring solutions. Co. delivers remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Co.'s Bioflux is an integrated electrocardiogram device and software solution for the mobile cardiac telemetry market. The Bioflux platform has a built-in cellular chipset and a real-time embedded operating system which allows for Co.'s technology to be utilized as an Internet of Things platform. This technology can be utilized into other applications and industries by utilizing the platform and OS side of Bioflux. The BTCY average annual return since 2018 is shown above.
The Average Annual Return on the BTCY average annual return since 2018 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether BTCY average annual return since 2018 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the BTCY average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|